These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33952308)

  • 41. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Education as Proxy for Cognitive Reserve in a Large Elderly Memory Clinic: 'Window of Benefit'.
    Staekenborg SS; Kelly N; Schuur J; Koster P; Scherder E; Tielkes CEM; Scheltens P; Claus JJ
    J Alzheimers Dis; 2020; 76(2):671-679. PubMed ID: 32538838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
    Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
    Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan.
    Sun Y; Lee HJ; Yang SC; Chen TF; Lin KN; Lin CC; Wang PN; Tang LY; Chiu MJ
    PLoS One; 2014; 9(6):e100303. PubMed ID: 24940604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relations of neuropsychiatric symptoms with disease stage, sex, and daily function in mild cognitive impairment and dementia due to Alzheimer's disease: A cross-sectional study.
    Zhang W; Wang X; Lü Y; Yu W
    J Psychosom Res; 2022 Oct; 161():110994. PubMed ID: 35939891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Educational attainment and hippocampal atrophy in the Alzheimer's disease neuroimaging initiative cohort.
    Shpanskaya KS; Choudhury KR; Hostage C; Murphy KR; Petrella JR; Doraiswamy PM;
    J Neuroradiol; 2014 Dec; 41(5):350-7. PubMed ID: 24485897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study.
    Mouton A; Blanc F; Gros A; Manera V; Fabre R; Sauleau E; Gomez-Luporsi I; Tifratene K; Friedman L; Thümmler S; Pradier C; Robert PH; David R
    Alzheimers Res Ther; 2018 Sep; 10(1):92. PubMed ID: 30208961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group.
    Andersen K; Launer LJ; Dewey ME; Letenneur L; Ott A; Copeland JR; Dartigues JF; Kragh-Sorensen P; Baldereschi M; Brayne C; Lobo A; Martinez-Lage JM; Stijnen T; Hofman A
    Neurology; 1999 Dec; 53(9):1992-7. PubMed ID: 10599770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The evaluation of thiol-disulfıte balance, ischemıa albumın modıfıcation and seruloplazmine as a new oxidatıve stress in mild cognitive impairment and early stage alzheimer's disease patients.
    Gündüztepe Y; Bukan N; Zorlu E; Karaman Y; Andaç Topkan T; Gurbuz N; Neşelioğlu S; Erel Ö
    J Clin Neurosci; 2020 May; 75():188-194. PubMed ID: 32223973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maintaining health and wellness in the face of dementia: an exploratory analysis of individuals attending a rural and remote memory clinic.
    Dal Bello-Haas VP; O'Connell ME; Morgan DG
    Rural Remote Health; 2014; 14(3):2722. PubMed ID: 25100163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group.
    Gambassi G; Lapane KL; Landi F; Sgadari A; Mor V; Bernabie R
    Neurology; 1999 Aug; 53(3):508-16. PubMed ID: 10449112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
    Alty J; Bai Q; Li R; Lawler K; St George RJ; Hill E; Bindoff A; Garg S; Wang X; Huang G; Zhang K; Rudd KD; Bartlett L; Goldberg LR; Collins JM; Hinder MR; Naismith SL; Hogg DC; King AE; Vickers JC
    BMC Neurol; 2022 Jul; 22(1):266. PubMed ID: 35850660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease.
    Liesinger AM; Graff-Radford NR; Duara R; Carter RE; Hanna Al-Shaikh FS; Koga S; Hinkle KM; DiLello SK; Johnson MF; Aziz A; Ertekin-Taner N; Ross OA; Dickson DW; Murray ME
    Acta Neuropathol; 2018 Dec; 136(6):873-885. PubMed ID: 30219939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.
    Wessels AM; Tariot PN; Zimmer JA; Selzler KJ; Bragg SM; Andersen SW; Landry J; Krull JH; Downing AM; Willis BA; Shcherbinin S; Mullen J; Barker P; Schumi J; Shering C; Matthews BR; Stern RA; Vellas B; Cohen S; MacSweeney E; Boada M; Sims JR
    JAMA Neurol; 2020 Feb; 77(2):199-209. PubMed ID: 31764959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature.
    Boccardi V; Paolacci L; Remondini D; Giampieri E; Poli G; Curti N; Cecchetti R; Villa A; Ruggiero C; Brancorsini S; Mecocci P
    J Alzheimers Dis; 2019; 72(3):911-918. PubMed ID: 31658056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial.
    Craft S; Raman R; Chow TW; Rafii MS; Sun CK; Rissman RA; Donohue MC; Brewer JB; Jenkins C; Harless K; Gessert D; Aisen PS
    JAMA Neurol; 2020 Sep; 77(9):1099-1109. PubMed ID: 32568367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. APOEɛ4 Gene Dose and Sex Effects on Alzheimer's Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment.
    Hobel Z; Isenberg AL; Raghupathy D; Mack W; Pa J;
    J Alzheimers Dis; 2019; 71(2):647-658. PubMed ID: 31424388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex difference in Alzheimer's disease: An updated, balanced and emerging perspective on differing vulnerabilities.
    Dubal DB
    Handb Clin Neurol; 2020; 175():261-273. PubMed ID: 33008530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.